Washington Trust CO Merck & Co., Inc. Transaction History

Washington Trust CO

$2.71 Billion
Q2 2024

A detailed history of Washington Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Washington Trust CO holds 33,089 shares of MRK stock, worth $3.8 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

33,089

Previous 34,603 4.38%

Holding current value

$3.8 Million

Previous $4.57 Million 10.27%

% of portfolio

0.15%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $187,433 - $201,301	-1,514 Reduced 4.38%	33,089 $4.1 Million
Q1 2024 Apr 23, 2024	BUY	$113.24 - $131.95 $12,229 - $14,250	108 Added 0.31%	34,603 $4.57 Million
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $81,145 - $88,306	-810 Reduced 2.29%	34,495 $3.76 Million
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $25,634 - $28,468	-249 Reduced 0.7%	35,305 $3.63 Million
Q2 2023 Jul 27, 2023	BUY	$108.61 - $118.38 $22,916 - $24,978	211 Added 0.6%	35,554 $4.1 Million
Q1 2023 May 10, 2023	BUY	$102.94 - $114.86 $3.73 Million - $4.16 Million	36,199 Added 100552.78%	36,235 $3.86 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $3.63 Million - $4.06 Million	-35,307 Reduced 99.9%	36 $3.86 Million
Q4 2022 Jul 27, 2023	SELL	$87.44 - $112.11 $77,996 - $100,002	-892 Reduced 2.46%	35,343 $3.92 Million
Q4 2022 Feb 08, 2023	SELL	$87.44 - $112.11 $51,152 - $65,584	-585 Reduced 1.63%	35,343 $3.92 Million
Q3 2022 Oct 14, 2022	BUY	$84.53 - $94.96 $60,608 - $68,086	717 Added 2.04%	35,928 $3.1 Million
Q2 2022 Jul 25, 2022	BUY	$83.49 - $94.64 $99,186 - $112,432	1,188 Added 3.49%	35,211 $3.21 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $42,341 - $47,462	576 Added 1.72%	34,023 $2.79 Million
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $713,981 - $894,354	-9,878 Reduced 22.8%	33,447 $2.56 Million
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $58,920 - $64,798	-822 Reduced 1.86%	43,325 $3.25 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $60,185 - $66,571	-856 Reduced 1.9%	44,147 $3.43 Million
Q1 2021 Apr 28, 2021	SELL	$68.86 - $81.11 $13,496 - $15,897	-196 Reduced 0.43%	45,003 $3.47 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $29,497 - $32,736	411 Added 0.92%	45,199 $3.7 Million
Q3 2020 Nov 05, 2020	SELL	$73.18 - $82.95 $102,964 - $116,710	-1,407 Reduced 3.05%	44,788 $3.72 Million
Q2 2020 Aug 04, 2020	SELL	$70.42 - $80.13 $1.75 Million - $1.99 Million	-24,891 Reduced 35.02%	46,195 $3.53 Million
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $145,791 - $202,073	2,301 Added 3.35%	71,086 $5.47 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $488,210 - $550,889	6,293 Added 10.07%	68,785 $6.26 Million
Q3 2019 Nov 06, 2019	SELL	$76.08 - $82.93 $24,117 - $26,288	-317 Reduced 0.5%	62,492 $5.42 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $12,361 - $14,441	-177 Reduced 0.28%	62,809 $5.27 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $465,211 - $530,600	-6,686 Reduced 9.6%	62,986 $4.92 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $382,632 - $444,039	-5,865 Reduced 7.76%	69,672 $5.32 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $19,095 - $22,455	-331 Reduced 0.44%	75,537 $5.36 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $1.49 Million - $1.75 Million	29,362 Added 63.14%	75,868 $4.61 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $16,409 - $19,072	-322 Reduced 0.69%	46,506 $2.53 Million
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $22,041 - $26,320	427 Added 0.92%	46,828 $2.64 Million
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $2.72 Million - $2.93 Million	46,401	46,401 $2.97 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $291B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Merck & Co., Inc. Transaction History